Decoding the Inflammatory–Metabolic Axis in Atherosclerosis: A New Frontier in Cardiovascular Prevention- by Atherosclerosis
Atherosclerosis published on X:
“Metabolic, renal, and inflammatory crosstalk in atherosclerotic cardiovascular disease: Evolving landscape and future directions.”
Title: Metabolic, renal, and inflammatory crosstalk in atherosclerotic cardiovascular disease: Evolving landscape and future directions.
Authors: Harris Avgousti, Matthew J. Feinstein
This recent publication in Atherosclerosis explores the complex interplay between metabolic dysfunction, renal impairment, and systemic inflammation in driving atherosclerotic cardiovascular disease (ASCVD). The review highlights how shared molecular pathways—such as oxidative stress, cytokine cascades, and metabolic-renal feedback loops—converge to accelerate plaque progression and vascular injury.
The authors emphasize a paradigm shift toward integrated, multi-system prevention strategies, including anti-inflammatory therapies, metabolic modulation, and kidney function preservation. This evolving understanding holds promise for personalized ASCVD management and novel therapeutic targets.
Read the abstract: Atherosclerosis Journal (June 2025).
See more in Hemostasis Today.
-
Aug 21, 2026, 14:32Kenneth Nollet: Building the Future of Transfusion Laboratory Science
-
Aug 21, 2026, 14:14Tareq Abadl: A Positive Antibody Screen is Not The Diagnosis
-
Aug 21, 2026, 14:08Katrina Snow։ Transfusion Trends and Quality Improvement in Sickle Cell Disease
-
Aug 21, 2026, 14:00Rucha Patil: The Power of Point-of-Care Testing in Hemostasis
-
Aug 21, 2026, 13:56Sarah Kowalski։ Supporting the Next Generation of Transfusion Laboratory Scientists
-
Aug 21, 2026, 13:51Join EHC 2026 Annual Conference
-
Aug 21, 2026, 12:57David McIntosh: Why Do Blood Supplies Still Fall Short?
-
Aug 21, 2026, 12:48Joshua Penrod: 35 Years of Progress in Plasma Safety
-
Aug 21, 2026, 12:42Moustafa Abdou: Diagnosis and Management of Pyruvate Kinase Deficiency